Alopecia areata trials in South Korea

In South Korea 8 Also abroad 44

8 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Where
Busan, Cheonan-si, Daejeon, Incheon, Jeonju, Junggu, Seongnam-si, Seoul, Suwon
Age
6 years to 17 years
People
595 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT05723198 · EU 2022-502700-78-00
Phase 2Taking people
A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
Where
Dongjak-gu, Incheon, Jeonju, Seoul
Age
18 years to 60 years
People
65 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07533006 · EU 2025-524727-41-00
Phase 3Taking people
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
Where
Jeonju, Seoul
Age
12 years and over
People
336 worldwide
Run by
Pfizer
See details and how to joinNCT07733765
Phase 3Taking people
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
Where
Busan, Cheonan-si, Daegu, Jeonju, Seongnam, Seoul
Age
12 years and over
People
674 worldwide
Run by
Pfizer
See details and how to joinNCT06873945 · EU 2024-519370-40-00
Phase 3Active, not recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Where
Busan, Daegu, Daejeon, Incheon, Jeonju, Seongnam-si, Seoul
Age
12 years to 63 years
People
1,500 worldwide
Run by
AbbVie
See details and how to joinNCT06012240 · EU 2023-505061-82-01
No phaseTaking people
A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice.
Where
Seoul
Age
12 years and over
People
3,000
Run by
Pfizer
See details and how to joinNCT07152119
Phase 2Taking people
Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata
Where
Seoul
Age
19 years to 65 years
People
73
Run by
NEXTGEN Bioscience
See details and how to joinNCT06104839
No phaseTaking people
A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa
Where
Seoul
Age
12 years and over
People
2,795 worldwide
Run by
AbbVie
See details and how to joinNCT07136467